text.skipToContent text.skipToNavigation
Need help? Please contact us

Video Showing the Division in CD34+ Human Cord Blood Hematopoietic Stem/Progenitor Cells

We have more articles for you

Article overview

Empowering NK cell immunotherapy research using a novel genome editing protocol

Efficient CRISPR RNP genome editing of human Natural Killer cell using the 4D-Nucleofector® Device

Short guideline for an efficient transfection using Nucleofection® Technology of human dendritic cells

We propose an efficient way to achieve good transfection results in terms of viability and efficiency using Nucleofection® Technology.

Using mesenchymal stem cells for therapeutic

The follow article will summarize the therapeutic properties of MSCs, quality attributes, expansion methods, as well as some major challenges these cells create when used in cell therapy applications. 

Interested in our webinars?

Need a break from your daily routine? Grab a coffee and check out our free webinars. 

Knowledge Center

Need technical data?

Browse our Cell and Transfection, Citation, FAQ and Culture Media Technical Databases.

Subscribe to our eNewsletter

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

References

Bujko K, Kucia M, Ratajczak J, Ratajczak MZ. Hematopoietic Stem and Progenitor Cells (HSPCs) Adv Exp Med Biol. 2019;1201:49-77

Franceschetti T and De Bari C. The potential role of adult stem cells in the management of the rheumatic diseases Ther. Adv. Musculoskelet. Dis. 2017 Vol. 9, no. 7, p. 165

Hawsawi YM, Al-Zahrani F, Mavromatis CH, Baghdadi MA, Saggu S, Oyouni AAA. Stem Cell Applications for Treatment of Cancer and Autoimmune Diseases: Its Promises, Obstacles, and Future Perspectives Technol. Cancer Res. Treat. 2018 Vol. 17, p. 1533033818806910

Hiildreth C. Hematopoietic Stem Cells: What Diseases Can these Stem Cells Treat? [Online] 2024

Kim DK, Fujiki Y, Fukushima T, Ema H, Shibuya A, Nakauchi H. Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells Stem Cells 1999 Vol. 17, no. 5, pp. 286–94

Kwak KA. Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease Stem Cells Int, 2018: 6392986

Morrison SJ, Wright DE, Cheshier SH, Weissman IL. Hematopoietic stem cells: challenges to expectations Curr. Opin. Immunol. 1997 Vol. 9, no. 2, pp. 216–221

Rush CA, Atkins HL, FreedmanMS. Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis Cold Spring Harb. Perspect. Med. 2019 Vol. 9, no. 3, p. a029082

Simmons DL, Satterthwaite AB, Tenen DG, Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells J. Immunol. 1992 Vol. 148, no. 1, pp. 267–71

Tyndall A and van Laar JM. Stem cells in the treatment of inflammatory arthritis Best Pract. Res. Clin. Rheumatol. 2010 Vol. 24, no. 4, pp. 565–574

Walasek MA, van Os R, de Haan G. Hematopoietic stem cell expansion: challenges and opportunities Ann N Y Acad Sci. 2012 Aug;1266:138-50  

Weissman IL and Shizuru JA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases Blood 2008 Vol. 112, no. 9, pp. 3543–53